Tanya Lewis

Insider Reports History

Entity
Individual
Location
C/O Karyopharm Therapeutics Inc., 85 Wells Ave., Newton, MA
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tanya Lewis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Chief Dev. Op. Officer Common Stock 135K $1.48M $10.92 Jun 13, 2023 Direct
DiaMedica Therapeutics Inc. Director Voting Common Shares, no par value per share 0 $0 $2.80 Jun 1, 2024 Direct
DiaMedica Therapeutics Inc. Director Stock Option (right to buy) 28.5K Jun 1, 2024 Direct

Insider Reports Filed by Tanya Lewis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jun 1, 2024 1 $0 4 Jun 3, 2024 Director
REPL Replimune Group, Inc. Jun 13, 2023 2 -$309K 4 Jun 15, 2023 Chief Dev. Op. Officer
DMAC DiaMedica Therapeutics Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Director
REPL Replimune Group, Inc. May 16, 2023 1 -$220K 4 May 18, 2023 Chief Dev. Op. Officer
REPL Replimune Group, Inc. Apr 1, 2023 2 $0 4 Apr 4, 2023 Chief Dev. Op. Officer
DMAC DiaMedica Therapeutics Inc. Mar 1, 2023 1 $0 4 Mar 6, 2023 Director
DMAC DiaMedica Therapeutics Inc. Mar 1, 2023 0 $0 3 Mar 6, 2023 Director
REPL Replimune Group, Inc. May 16, 2022 1 -$79.9K 4 May 18, 2022 Chief Dev. Op Officer
REPL Replimune Group, Inc. Apr 1, 2022 2 $0 4 Apr 5, 2022 Chief Dev.Op Off
REPL Replimune Group, Inc. May 10, 2021 2 $0 4 May 11, 2021 Chief Dev. Oper. Off.